We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.23B
AUM Growth
-$1.26B
(-15%)
Cap. Flow
-$1.29B
Cap. Flow
% of AUM
-17.85%
Top 10 Holdings %
Top 10 Hldgs %
17.57%
Holding
1,950
New
32
Increased
184
Reduced
1,428
Closed
301
Top Buys
| 1 |
Equinix
EQIX
|
+$4.63M |
| 2 |
Consolidated Edison
ED
|
+$2.41M |
| 3 |
ProShares Global Listed Private Equity ETF
PEX
|
+$2.33M |
| 4 |
Sysco
SYY
|
+$2.07M |
| 5 |
Pentair
PNR
|
+$1.95M |
Top Sells
| 1 |
Apple
AAPL
|
+$94.7M |
| 2 |
Microsoft
MSFT
|
+$47.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$38.2M |
| 4 |
Gilead Sciences
GILD
|
+$21.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$20.9M |
Sector Composition
| 1 | Healthcare | 20.1% |
| 2 | Technology | 15.48% |
| 3 | Financials | 15.36% |
| 4 | Consumer Discretionary | 7.61% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.89T
| $322M | 4.45% |
10,258,872
-2,960,768
| -22% | -$94.7M |
|
|
2
Microsoft
MSFT
$2.98T
| $156M | 2.17% |
3,544,334
-1,042,451
| -23% | -$47.6M |
|
|
3
Alphabet (Google) Class C
GOOG
$4.32T
| $136M | 1.88% |
5,135,180
-1,426,867
| -22% | -$38.2M |
|
|
4
Gilead Sciences
GILD
$169B
| $125M | 1.73% |
1,067,344
-198,987
| -16% | -$21.7M |
|
5
ExxonMobil
XOM
$605B
| $98.5M | 1.36% |
1,184,436
-166,502
| -12% | -$14.3M |
|
6
Amgen
AMGN
$201B
| $97.4M | 1.35% |
634,264
-68,576
| -10% | -$11M |
|
7
Biogen
BIIB
$30.8B
| $88.1M | 1.22% |
218,087
-18,958
| -8% | -$7.61M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $85.8M | 1.19% |
741,524
-53,358
| -7% | -$6.1M |
|
|
9
Meta Platforms (Facebook)
META
$1.69T
| $80.9M | 1.12% |
943,646
-256,276
| -21% | -$20.9M |
|
10
JPMorgan Chase
JPM
$912B
| $79.5M | 1.1% |
1,173,792
-182,212
| -13% | -$11.9M |
|
11
Amazon
AMZN
$2.69T
| $75.5M | 1.05% |
3,480,520
-980,820
| -22% | -$20.5M |
|
12
Johnson & Johnson
JNJ
$602B
| $74.7M | 1.03% |
766,502
-93,339
| -11% | -$9.35M |
|
13
Wells Fargo
WFC
$267B
| $74M | 1.02% |
1,315,435
-191,491
| -13% | -$10.7M |
|
14
Intel
INTC
$487B
| $70.7M | 0.98% |
2,324,726
-642,327
| -22% | -$20.8M |
|
15
Berkshire Hathaway Class B
BRK.B
$1.06T
| $69.7M | 0.97% |
512,354
-73,559
| -13% | -$10.5M |
|
16
Chevron
CVX
$366B
| $63.6M | 0.88% |
659,487
-89,352
| -12% | -$9.38M |
|
17
Cisco
CSCO
$432B
| $62.4M | 0.86% |
2,271,999
-637,537
| -22% | -$18.3M |
|
18
Regeneron Pharmaceuticals
REGN
$71.2B
| $59.8M | 0.83% |
117,160
-11,278
| -9% | -$5.5M |
|
19
Comcast
CMCSA
$86.1B
| $53.4M | 0.74% |
1,776,070
-519,540
| -23% | -$15.3M |
|
20
Procter & Gamble
PG
$353B
| $51M | 0.71% |
652,086
-75,903
| -10% | -$6.11M |
|
21
Bank of America
BAC
$432B
| $50.2M | 0.7% |
2,951,500
-418,685
| -12% | -$6.9M |
|
22
Citigroup
C
$221B
| $49.5M | 0.68% |
895,979
-76,363
| -8% | -$4.15M |
|
23
Goldman Sachs
GS
$323B
| $48.9M | 0.68% |
234,147
-45,563
| -16% | -$9.28M |
|
|
WBA
24
DELISTED
Walgreens Boots Alliance
WBA
| $48.2M | 0.67% |
571,132
-114,390
| -17% | -$9.86M |
|
25
3M
MMM
$84.4B
| $45.4M | 0.63% |
351,679
-43,820
| -11% | -$5.88M |
|
Similar funds
ProShare Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, ProShare Advisors held 1,950 positions worth $7.23B, down 15% from $8.49B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors withdrew a net $1.29B in Q2 2015, closing 301 positions and reducing 1,428 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $16.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, ProShare Advisors opened a new position in Uniti Group worth $1.66M.
- ProShare Advisors's largest Q2 2015 buy was Uniti Group: 67,007 shares worth $1.66M.
- ProShare Advisors added most to Equinix in Q2 2015, an estimated $4.63M increase.
- ProShare Advisors's biggest Q2 2015 reduction was Apple, cutting an estimated $94.7M.
- ProShare Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $16.5M.
- ProShare Advisors's ten largest holdings make up 18% of its $7.23B portfolio in Q2 2015.
- ProShare Advisors opened 32 new positions and closed 301 in Q2 2015.
- ProShare Advisors's portfolio value fell 15% quarter-over-quarter to $7.23B.
Based on ProShare Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.